SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-013771
Filing Date
2019-07-29
Accepted
2019-07-29 06:05:28
Documents
3
Period of Report
2019-07-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k072919_alteritytherap.htm 6-K 14098
2 ALTERITY THERAPEUTICS ANNOUNCES SUCCESSFUL COMPLETION OF PHASE 1 CLINICAL TRIAL f6k072919ex99-1_alterity.htm EX-99.1 11973
3 GRAPHIC eximg_001.jpg GRAPHIC 13916
  Complete submission text file 0001213900-19-013771.txt   46475
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 19979290
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1